CeGaT Expands Genetic Testing Services to U.S. and Canada, Partnering with Major Insurers
CeGaT, a global provider of genetic testing and sequencing services, announces the expansion of its world-class genetic…
CeGaT, a global provider of genetic testing and sequencing services, announces the expansion of its world-class genetic…
CeGaT, a global provider of genetic diagnostics and sequencing services, presents an innovation in exome diagnostics: Wi…
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QIAGEN Clinical Insight (QCI®), its clinical dec…
CeGaT GmbH, a leading global genetic testing provider focused on large panel and trio-exome diagnostics, has obtained it…
Centogene AG (CENTOGENE) and Interactive Biosoftware (IBS) announce to start their collaboration on the integration of C…
Collaboration between FDNA, the developer of the Face2Gene Suite and CENTOGENE, worldwide leader in genetic diagnostics,…
With the upcoming release of CentoMD® 3.1 end of September 2016, CENTOGENE will report genetic information and clinical…
CENTOGENE AG (“CENTOGENE”) announces the launch of the completely updated CentoMD® 3.0 CentoMD®, the world’s leading pr…
Eurofins MWG Operon, pioneer and key provider of next generation sequencing services (NGS) is proud to announce the laun…
Leading NGS service company joins Life Technologies' global network of next generation-based exome sequencing provider.…